Our project did not address the known disparities in insulin pump technology use for youth with T1D, such as limitations by insurance types, race, ethnicity, education level, and socioeconomic status, as noted in national registries.21 However, we plan to leverage the EMR to track these data, to better understand and address the impact of social drivers on technology uptake at our institution, and to compare the outcomes to national metrics. This evidence concerns the gene INS and type 1 diabetes mellitus.